Bladder cancer, Transitional cell cancer
Open
Phase 1
This trial is looking at having atezolizumab directly into the bladder followed by surgery.
It is for people who are due to have surgery to remove their bladder (a
Recruitment start: 4 May 2023
Recruitment end: 28 February 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Syed Hussain
F. Hoffmann - La Roche, Limited
Leeds Institute of Clinical Trials Research at the University of Leeds and the University of Sheffield
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield
Last reviewed: 2 July 2025
CRUK internal database number: 18863